pharmaceutical investing
Signal vs. Noise: What a Paracetamol Study Teaches Investors About Market Volatility
A landmark medical study offers a profound lesson for investors on risk assessment, data analysis, and the high cost of market misinformation.
A Transatlantic Bet: Why a UK Pharma Titan is Doubling Down on the US
A UK pharma giant’s CEO champions US expansion, a powerful signal about global capital flow, policy, and the future of the UK’s innovation economy.
The Billion-Dollar Glow: Decoding Clinuvel’s High-Stakes Quest for a Medical Marvel
The story of Clinuvel, a biotech firm with a proven drug, betting its future on the holy grail of cosmetics: a true sunless tanning cream.